Virtu KCG Holdings’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-18,042
Closed -$462K – 3055
2017
Q1
$462K Buy
18,042
+4,476
+33% +$112K 0.01% 1466
2016
Q4
$328K Buy
+13,566
New +$317K 0.01% 1980
2016
Q3
– Sell
-10,294
Closed -$221K – 3187
2016
Q2
$221K Sell
10,294
-26,323
-72% -$554K ﹤0.01% 2217
2016
Q1
$773K Buy
+36,617
New +$739K 0.02% 782
2015
Q3
– Sell
-16,568
Closed -$416K – 3484
2015
Q2
$416K Buy
+16,568
New +$415K 0.01% 1669

Other funds holding FFTY

Virtu KCG Holdings's FFTY Position: Q2 2017 in Review

Virtu KCG Holdings sold out of CapForce IBD 50 ETF (FFTY) in Q2 2017, closing a stake of 18,042 shares — an estimated $462K sold.

Virtu KCG Holdings first reported a position in FFTY in Q2 2015 and held it in 5 quarters. The position peaked at $773K in Q1 2016. 18 funds tracked by Wall St. Rank hold FFTY as of Q2 2017.

  • Virtu KCG Holdings reported no remaining CapForce IBD 50 ETF position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 18,042 CapForce IBD 50 ETF shares in Q2 2017, an estimated $462K.
  • Virtu KCG Holdings first reported a position in CapForce IBD 50 ETF in Q2 2015 and held it in 5 quarters.
  • Virtu KCG Holdings's CapForce IBD 50 ETF position peaked at $773K in Q1 2016.
  • 18 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.